Frederick L. Moolten

2.2k total citations · 1 hit paper
22 papers, 1.7k citations indexed

About

Frederick L. Moolten is a scholar working on Molecular Biology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Frederick L. Moolten has authored 22 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Genetics and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Frederick L. Moolten's work include Virus-based gene therapy research (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Toxin Mechanisms and Immunotoxins (3 papers). Frederick L. Moolten is often cited by papers focused on Virus-based gene therapy research (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Toxin Mechanisms and Immunotoxins (3 papers). Frederick L. Moolten collaborates with scholars based in United States and Canada. Frederick L. Moolten's co-authors include Nancy L. R. Bucher, Sidney R. Cooperband, Richard A. Heyman, Ronald M. Evans, John M. Wells, Robert L. Martuza, Xandra O. Breakefield, Christina Fleet, L. Adrienne Cupples and M. Priscilla Short and has published in prestigious journals such as Nature, Science and JNCI Journal of the National Cancer Institute.

In The Last Decade

Frederick L. Moolten

21 papers receiving 1.6k citations

Hit Papers

Tumor chemosensitivity conferred by inserted herpes thymi... 1986 2026 1999 2012 1986 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy.
    1986 817 citations Frederick L. Moolten PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frederick L. Moolten United States 15 946 879 410 408 304 22 1.7k
S L Woo United States 16 567 0.6× 698 0.8× 265 0.6× 247 0.6× 116 0.4× 23 1.4k
Deborah DeFeo United States 9 488 0.5× 1.1k 1.3× 417 1.0× 72 0.2× 59 0.2× 11 1.6k
Sabine Schirm United States 16 196 0.2× 891 1.0× 452 1.1× 190 0.5× 38 0.1× 27 1.5k
M Shearer United Kingdom 20 222 0.2× 782 0.9× 660 1.6× 148 0.4× 50 0.2× 27 1.6k
Shiun‐Kwei Chiou United States 15 335 0.4× 863 1.0× 574 1.4× 133 0.3× 170 0.6× 24 1.4k
Joëlle Sobczak‐Thépot France 22 275 0.3× 1.5k 1.7× 708 1.7× 120 0.3× 52 0.2× 40 1.9k
E K Russell United States 19 245 0.3× 1.3k 1.5× 840 2.0× 363 0.9× 78 0.3× 24 2.0k
H.‐G. Thiele Germany 23 226 0.2× 545 0.6× 451 1.1× 169 0.4× 43 0.1× 75 1.8k
Jack A. Roth United States 17 725 0.8× 1.1k 1.3× 906 2.2× 71 0.2× 457 1.5× 28 1.9k
Randy Talbott United States 12 343 0.4× 1.1k 1.2× 561 1.4× 470 1.2× 123 0.4× 18 1.9k

Countries citing papers authored by Frederick L. Moolten

Since Specialization
Citations

This map shows the geographic impact of Frederick L. Moolten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick L. Moolten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick L. Moolten more than expected).

Fields of papers citing papers by Frederick L. Moolten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick L. Moolten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick L. Moolten. The network helps show where Frederick L. Moolten may publish in the future.

Co-authorship network of co-authors of Frederick L. Moolten

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick L. Moolten. A scholar is included among the top collaborators of Frederick L. Moolten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick L. Moolten. Frederick L. Moolten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Moolten, Frederick L., et al.. (1993). Retrovirally Transduced Escherichia coli gpt Genes Combine Selectability with Chemosensitivity Capable of Mediating Tumor Eradication. Human Gene Therapy. 4(5). 589–595. 27 indexed citations
4.
Takamiya, Yoshiaki, M. Priscilla Short, Frederick L. Moolten, et al.. (1993). An experimental model of retrovirus gene therapy for malignant brain tumors. Journal of neurosurgery. 79(1). 104–110. 124 indexed citations
5.
Moolten, Frederick L. & L. Adrienne Cupples. (1992). A Model for Predicting the Risk of Cancer Consequent to Retroviral Gene Therapy. Human Gene Therapy. 3(5). 479–486. 35 indexed citations
6.
Moolten, Frederick L., John M. Wells, Richard A. Heyman, & Ronald M. Evans. (1990). Lymphoma Regression Induced by Ganciclovir in Mice Bearing a Herpes Thymidine Kinase Transgene. Human Gene Therapy. 1(2). 125–134. 161 indexed citations
7.
Moolten, Frederick L.. (1987). An alternative to the magic bullet paradigm for specific cancer therapy. Medical Hypotheses. 24(1). 43–51. 6 indexed citations
8.
Moolten, Frederick L.. (1986). In vivo efficacy of HAT therapy against transplantable murine myelomas resistant to purine analogs. Cancer Letters. 31(3). 305–309. 1 indexed citations
9.
10.
Moolten, Frederick L., et al.. (1981). Protection of mice against 7,12-dimethylbenz(a)anthracene-induced skin tumors by immunization with a fluorinated analog of the carcinogen.. PubMed. 41(2). 425–9. 16 indexed citations
11.
Oh, Se‐Kyung & Frederick L. Moolten. (1981). Purification and characterization of an immunosuppressive factor from ovarian cancer ascites fluid. European Journal of Immunology. 11(10). 780–788. 15 indexed citations
12.
Moolten, Frederick L. & Barbara M. Schreiber. (1980). Formation of adherent monolayers of murine lymphocytes in vitro: The use of serum-free medium and concanavalin a-coated surfaces to promote adherence. Journal of Immunological Methods. 36(3-4). 359–368. 5 indexed citations
13.
Moolten, Frederick L., et al.. (1978). Induction of antibodies against carcinogenic polycyclic aromatic hydrocarbons. Nature. 272(5654). 614–616. 28 indexed citations
14.
Cooperband, Sidney R., et al.. (1977). Characterization of antigen-binding receptors in vitro. I. An equilibrium method for measuring antigen binding in murine cells.. PubMed. 119(4). 1427–31. 2 indexed citations
15.
Moolten, Frederick L.. (1976). Genetic mosaicism and the control of cancer. Medical Hypotheses. 2(3). 79–81. 3 indexed citations
16.
Moolten, Frederick L., et al.. (1975). Antitumor Effects of Antibody—Diphtheria Toxin Conjugates. III. Cyclophosphamide-Induced Immune Unresponsiveness to Conjugates2. JNCI Journal of the National Cancer Institute. 55(3). 709–712. 34 indexed citations
17.
Moolten, Frederick L., et al.. (1972). Antitumor Effects of Antibody-Diphtheria Toxin Conjugates: Use of Hapten-Coated Tumor Cells as an Antigenic Target<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 49(4). 1057–62. 40 indexed citations
18.
Moolten, Frederick L. & Sidney R. Cooperband. (1970). Selective Destruction of Target Cells by Diphtheria Toxin Conjugated to Antibody Directed against Antigens on the Cells. Science. 169(3940). 68–70. 130 indexed citations
19.
Moolten, Frederick L., et al.. (1970). Accelerated response of hepatic DNA synthesis to partial hepatectomy in rats pretreated with growth hormone or surgical stress.. PubMed. 30(9). 2353–7. 45 indexed citations
20.
Efron, Robert, Edwin O. Willis, Frederick L. Moolten, et al.. (1968). Letters to and from the Editor. Perspectives in biology and medicine. 12(1). 163–176. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S L Woo Breakdown of academic impact, for papers by Deborah DeFeo Breakdown of academic impact, for papers by Sabine Schirm Breakdown of academic impact, for papers by M Shearer Breakdown of academic impact, for papers by Shiun‐Kwei Chiou Breakdown of academic impact, for papers by Joëlle Sobczak‐Thépot Breakdown of academic impact, for papers by E K Russell Breakdown of academic impact, for papers by H.‐G. Thiele Breakdown of academic impact, for papers by Jack A. Roth Breakdown of academic impact, for papers by Randy Talbott
Rankless by CCL
2026